Tai Sandi See insider trades

Open-market stock purchases and sales by Tai Sandi See, Chief Development Officer at Lexeo Therapeutics, Inc, from SEC Form 4 filings since Jan 7, 2025.

Recent trades

DateStockTradeValue
Nov 18, 2025LXEO Lexeo Therapeutics, IncSold$3.6K
Oct 17, 2025LXEO Lexeo Therapeutics, IncSold$34.3K
Oct 17, 2025LXEO Lexeo Therapeutics, IncSold$421
Oct 15, 2025LXEO Lexeo Therapeutics, IncBought (not open market)—

Companies traded

  • LXEO Lexeo Therapeutics, Inc: 6 sales, last Nov 18, 2025

Get free alerts when Tai Sandi See files a new trade →